InspireMD
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4 Menorat Hamaor St, Tel Aviv, Tel Aviv,...Phone Number
+972 36917691Website
www.inspiremd.comRevenue
$10.8 MillionStock Symbol
NSPRIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About InspireMD
InspireMD, Inc., is a medical device company that is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases. InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable stroke free long-term outcomes. InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the ticker symbol NSPR.WS and NSPR.WSB. The company is based in Tel Aviv, Israel.Explore more
InspireMD Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InspireMD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on InspireMD recently announced quarterly report
Funding: Get notified immidiatlly once InspireMD has new funding data
Check if InspireMD has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when InspireMD launches new products
Click to see if InspireMD had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at InspireMD
Website visits: Recent activity has been detected on your website
Check out if InspireMD is spiking on competitors!
InspireMD, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
InspireMD is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
InspireMD is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about InspireMD.
InspireMD financials insights
Gather financial insights about InspireMD, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Debt
$11M
2025
Stock/Share Issuance
$40.1M
Stock/Share Issuance
$58M
InspireMD Tech Stack
A closer look at the technologies used by InspireMD
Most Recent Scoops
Hiring Plans
InspireMD has more open roles in Operations than it has had at any time in the past 6 months.
Hiring Plans
Earnings
reported total revenue of $3.1 million for Q4 2025, an increase of 62% compared to revenue of $1.9 million for Q4 2024. This growth was driven by the launch of CGuard Prime in the US and increased penetration of international markets with CGuard.
Earnings, Product Launch, Finance
Earnings
reported international revenue of $2.3 million for Q4 2025, reflecting growth of 17% compared to $1.9 million for Q4 2024. The majority of the international growth was driven by higher unit sales, while changes in foreign exchange rates contributed growth of about 7% to international results.
Earnings, Finance
Earnings
reported total operating expenses of $13.3 million for Q4 2025, an increase of $3.4 million compared to $9.8 million for Q4 2024. This increase was primarily due to higher commercial staffing levels and marketing activities for the US commercial launch of CGuard Prime.
Earnings, Spending/Investment, Finance
Earnings
Earnings, Finance
InspireMD News & Media
InspireMD Reports Second Quarter 2026 Financial Results
- Company to host investor conference call today, August 17th, at 8:30am EDT -InspireMD to Announce Second Quarter 2026 Financial Results
MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced it will issue its press release for its second quarter financial results on Monday August 17, 2026. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD’s Board of Directors approved inducement grants to a new non-executive employee in the aggregate amount of 221,666 shares of restricted stock (the “Inducement Grants”) outside of InspireMD’s 2021 Equity Incentive Plan, with a grant date as of August 3,InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
Ms. Kennedy returns to InspireMD having previously served as Sales Director supporting the initial U.S. launch of CGuard Prime Ms. Kennedy returns to InspireMD having previously served as Sales Director supporting the initial U.S. launch of CGuard Prime
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InspireMD
Sign Up For FreeTo access detailed company insights
InspireMD, Inc., is a medical device company that is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases. InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting by providing outst... Read More
